Product logins

Find logins to all Clarivate products below.


ENT Devices | Market Insights | Europe (Supplemental) | 2021

The COVID-19 pandemic will have a significant impact on ENT procedure volumes in the short term. Once the market stabilizes, however, ENT procedure volumes will grow slightly in Europe through 2029, due to growing developments in alternative treatment such as anitbiotics and continued effort of various associations to promote alternatives to surgery. However, ongoing adoption of premium-priced devices, and a general trend toward flexible endoscopy will result in slow growth of this market through 2029.

This Medtech 360 Report provides key market metrics for the GI endoscopy device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Dental Implants – Market Insights – Europe
The European dental implant market is projected to experience modest expansion through 2035. Growth is driven by an aging population with ongoing long-term restorative needs, a persistent burden of…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…